Primary aldosteronism, a common entity? the myth persists (Q34565020)

3 August 2017

1 reference

title

Primary aldosteronism, a common entity? the myth persists (English)

1 reference

3 August 2017

Padfield PL

1

1 reference

3 August 2017

language of work or name

1 reference

1 March 2002

1 reference

Journal of Human Hypertension

3 August 2017

published in

1 reference

3 August 2017

volume

16

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

159-162

1 reference

Low-renin ("primary") hyperaldosteronism. Differential diagnosis and distinction of sub-groups within the syndrome

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001321

Primary aldosteronism: diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001321

Diagnosis of primary hyperaldosteronism: importance of correlating CT findings with endocrinologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001321

Is low-renin hypertension a stage in the development of essential hypertension or a diagnostic entity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001321

Increased Adrenal Sensitivity to Angiotensin II in Idiopathic Hyperaldosteronism*

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001321

Enhanced aldosterone response to angiotensin II in human hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001321

Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001321

Primary aldosteronism: revival of a syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001321

High prevalence of primary aldosteronism in the Tayside hypertension clinic population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001321

Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001321

Cautions over the current epidemic of primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001321

The myth of idiopathic hyperaldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001321

7 January 2021

Aldosteronism in hypertension. The spironolactone response test

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001321

7 January 2021

The syndrome of essential hypertension and suppressed plasma renin activity. Normalization of blood pressure with spironolactone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001321

7 January 2021

A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001321

7 January 2021

Mineralocorticoid hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001321

7 January 2021

Identifiers

DOI

10.1038/SJ.JHH.1001321

1 reference

Dimensions Publication ID

3 August 2017

1019237016

0 references

1 reference